Skip to main content

Table 1 Expression of BBOX1-AS1 and its associations with clinical features, prognosis, and diagnosis in human tumor samples

From: A review on the role of gamma-butyrobetaine hydroxylase 1 antisense RNA 1 in the carcinogenesis and tumor progression

Tumor type

Expression

Significant clinical features

Prognosis

Diagnosis

Ref.

Tumor vs. normal tissues

Fold change

Sample size

Pituitary adenoma

Upregulated

~ 6.5-fold

38 pairs of adenoma and adjacent normal tissues (qRT-PCR)

[34]

Oral squamous cell carcinoma

Upregulated

~ 4-fold

50 pairs of adenoma and adjacent normal tissues (qRT-PCR)

[35]

Nasopharyngeal carcinoma

Upregulated

~ 2.5-fold

45 pairs of adenoma and adjacent normal tissues (qRT-PCR)

[37]

Nasopharyngeal carcinoma

Upregulated

~ 6-fold

45 paired of adenoma and adjacent normal tissues (qRT-PCR)

[36]

Non-small cell lung cancer

Upregulated

~ 1.5-fold

135 pairs of adenoma and adjacent normal tissues (qRT-PCR)

Lymph node metastasis, TNM stage

OS

[40]

Non-small cell lung cancer

Upregulated

~ 2-fold

76 pairs of adenoma and adjacent normal tissues (qRT-PCR)

Tumor size, lymph node metastasis, TNM stage

OS

[39]

526 cancer and 59 normal samples in LUAD, and 501 cancer and 49 normal samples in LUSC (starBase v3.0 database)

486 cancer and 338 normal samples in LUSC (GEPIA database)

GEO datasets (GSE18842 and GSE19188)

Lung squamous cell carcinoma

Upregulated

3 pairs of LUSC tissues and normal lung tissues (qRT-PCR)

Ethnicity

AUC of 0.983 (95% CI 0.973–0.993, P < 0.0001)

[38]

502 cancer and 49 normal samples in LUSC (TCGA dataset)

GEO datasets (GSE19188, GSE30219, GSE103512, E‑MTAB‑5231)

Esophageal carcinoma

Upregulated

~ 12-fold

45 pairs of adenoma and adjacent normal tissues (qRT-PCR)

[45]

Esophageal squamous cell carcinoma

Upregulated

~ 2-fold

78 pairs of adenoma and adjacent normal tissues (qRT-PCR)

Tumor size, lymph node metastasis, TNM stage

OS

 

[44]

182 adenoma and 286 normal tissues (GEPIA database)

Esophageal squamous cell carcinoma

Upregulated

~ 2.75-fold

45 pairs of adenoma and adjacent normal tissues (qRT-PCR)

Tumor size

OS

AUC of 0.7668 (95% CI 0.6399 to 0.8937, P < 0.001)

[43]

182 adenoma and 13 normal tissues (GEPIA database)

Esophageal squamous cell carcinoma

Upregulated

182 adenoma and 286 normal tissues (GEPIA database)

[42]

162 cancer and 11 normal samples (starBase v3.0 database)

Esophageal carcinoma

Upregulated

~ 3.75-fold

45 pairs of adenoma and adjacent normal tissues (qRT-PCR)

Lymph node metastasis, TNM stage

OS

[41]

Gastric cancer

Upregulated

~ 3-fold

40 pairs of adenoma and adjacent normal tissues (qRT-PCR)

Lymph node metastasis

[48]

408 tumor samples and 211 normal samples (GEPIA database)

Hepatocellular carcinoma

Upregulated

~ 2-fold

83 pairs of adenoma and adjacent normal tissues (qRT-PCR)

Vascular invasion, TNM stage

OS

[46]

Hepatocellular carcinoma

Upregulated

~ 2-fold

374 tumor samples and 50 normal samples (GENCODE database)

Vascular invasion, tumor grade, tumor stage

OS, DFS

 

[47]

Ovarian cancer

Upregulated

426 tumor samples and 88 normal samples (TCGA database)

[51]

Cervical cancer

Upregulated

~ 2-fold

100 pairs of adenoma and adjacent normal tissues (qRT-PCR)

Tumor size, differentiation, distant metastasis, FIGO stage

OS

[53]

306 tumor samples and 13 normal samples (GEPIA database)

Cervical cancer

Upregulated

306 tumor samples and 13 normal samples (GEPIA database)

[52]

  1. qRT-PCR quantitative reverse transcription polymerase chain reaction, LUAD lung adenocarcinoma, LUSC lung squamous cell carcinoma, OS overall survival, DFS disease-free survival
  2. “–”: indicates missing or not applicable data